東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Colon cancer diagnosis and therapy.....

Shukla, Dhananjay.

FindBook

Google Book

Amazon

博客來

Colon cancer diagnosis and therapy.. Vol. 3

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Colon cancer diagnosis and therapy./ edited by Dhananjay Shukla, Naveen Kumar Vishvakarma, Ganji Purnachandra Nagaraju.
其他作者:	Shukla, Dhananjay.
出版者:	Cham :Springer International Publishing : : 2022.,
面頁冊數:	xvi, 460 p. :ill. (some col.), digital ;24 cm.
內容註:	Chapter 1. Role of chemokines in colorectal cancer -- Chapter 2. Extracellular vesicles in colorectal cancer growth, metastasis, diagnosis and therapy -- Chapter 3. Epigenetic regulation of colorectal cancer (CRC) -- Chapter 4. Mechanistic exploration and therapeutic management of colon cancer metastasis -- Chapter 5. Chemoresistance in colon malignancies -- Chapter 6. Targeting pathogenic inflammation for therapeutic intervention against colon cancer -- Chapter 7. Role of tumor associated macrophages in colon cancer progression and its therapeutic targeting -- Chapter 8. Therapeutic intervention of signaling pathways in colorectal cancer -- Chapter 9. Advances in chemoradiotherapy for treatment of colon cancer -- Chapter 10. Cytotoxic and chemopreventive activity of polyphenols and their derivatives in colon cancer -- Chapter 11. Prevention and management of colon cancer by nutritional intervention -- Chapter 12. Development of RNA based medicine for colorectal cancer -- Chapter 13. Role of food additives and intestinal microflora in colorectal cancer -- Chapter 14. Probiotics in colon cancer -- Chapter 15. Bacterial cancer therapy -- Chapter 16. Antineoplastic effects of curcumin against colorectal cancer -- Chapter 17. Cyanobacterial secondary metabolite -- Chapter 18. Clinical significance of genetic variants in colon cancer.
Contained By:	Springer Nature eBook
標題:	Colon (Anatomy) - Cancer -
電子資源:	https://doi.org/10.1007/978-3-030-72702-4
ISBN:	9783030727024

Colon cancer diagnosis and therapy.. Vol. 3
Colon cancer diagnosis and therapy.Vol. 3[electronic resource] /edited by Dhananjay Shukla, Naveen Kumar Vishvakarma, Ganji Purnachandra Nagaraju. - Cham :Springer International Publishing :2022. - xvi, 460 p. :ill. (some col.), digital ;24 cm.

Chapter 1. Role of chemokines in colorectal cancer -- Chapter 2. Extracellular vesicles in colorectal cancer growth, metastasis, diagnosis and therapy -- Chapter 3. Epigenetic regulation of colorectal cancer (CRC) -- Chapter 4. Mechanistic exploration and therapeutic management of colon cancer metastasis -- Chapter 5. Chemoresistance in colon malignancies -- Chapter 6. Targeting pathogenic inflammation for therapeutic intervention against colon cancer -- Chapter 7. Role of tumor associated macrophages in colon cancer progression and its therapeutic targeting -- Chapter 8. Therapeutic intervention of signaling pathways in colorectal cancer -- Chapter 9. Advances in chemoradiotherapy for treatment of colon cancer -- Chapter 10. Cytotoxic and chemopreventive activity of polyphenols and their derivatives in colon cancer -- Chapter 11. Prevention and management of colon cancer by nutritional intervention -- Chapter 12. Development of RNA based medicine for colorectal cancer -- Chapter 13. Role of food additives and intestinal microflora in colorectal cancer -- Chapter 14. Probiotics in colon cancer -- Chapter 15. Bacterial cancer therapy -- Chapter 16. Antineoplastic effects of curcumin against colorectal cancer -- Chapter 17. Cyanobacterial secondary metabolite -- Chapter 18. Clinical significance of genetic variants in colon cancer.

Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis. This book is the third of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coverage addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on immunotherapeutics, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer.

ISBN: 9783030727024

Standard No.: 10.1007/978-3-030-72702-4doiSubjects--Topical Terms:

1530575
Colon (Anatomy)
--Cancer

LC Class. No.: RC280.C6 / C65 2022

Dewey Class. No.: 616.99434706

Colon cancer diagnosis and therapy.. Vol. 3
LDR:03714nmm a2200325 a 4500 001 2298000
003 DE-He213
005 20220214044728.0
006 m d
007 cr nn 008maaau
008 230324s2022 sz s 0 eng d
020 $a 9783030727024 $q (electronic bk.)
020 $a 9783030727017 $q (paper)
024 7 $a 10.1007/978-3-030-72702-4 $2 doi
035 $a 978-3-030-72702-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.C6 $b C65 2022
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99434706 $2 23
090 $a RC280.C6 $b C719 2022
245 0 0 $a Colon cancer diagnosis and therapy. $n Vol. 3 $h [electronic resource] / $c edited by Dhananjay Shukla, Naveen Kumar Vishvakarma, Ganji Purnachandra Nagaraju.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a xvi, 460 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Chapter 1. Role of chemokines in colorectal cancer -- Chapter 2. Extracellular vesicles in colorectal cancer growth, metastasis, diagnosis and therapy -- Chapter 3. Epigenetic regulation of colorectal cancer (CRC) -- Chapter 4. Mechanistic exploration and therapeutic management of colon cancer metastasis -- Chapter 5. Chemoresistance in colon malignancies -- Chapter 6. Targeting pathogenic inflammation for therapeutic intervention against colon cancer -- Chapter 7. Role of tumor associated macrophages in colon cancer progression and its therapeutic targeting -- Chapter 8. Therapeutic intervention of signaling pathways in colorectal cancer -- Chapter 9. Advances in chemoradiotherapy for treatment of colon cancer -- Chapter 10. Cytotoxic and chemopreventive activity of polyphenols and their derivatives in colon cancer -- Chapter 11. Prevention and management of colon cancer by nutritional intervention -- Chapter 12. Development of RNA based medicine for colorectal cancer -- Chapter 13. Role of food additives and intestinal microflora in colorectal cancer -- Chapter 14. Probiotics in colon cancer -- Chapter 15. Bacterial cancer therapy -- Chapter 16. Antineoplastic effects of curcumin against colorectal cancer -- Chapter 17. Cyanobacterial secondary metabolite -- Chapter 18. Clinical significance of genetic variants in colon cancer.
520 $a Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis. This book is the third of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coverage addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on immunotherapeutics, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer.
650 0 $a Colon (Anatomy) $x Cancer $x Diagnosis. $3 1530575
650 0 $a Colon (Anatomy) $x Cancer $x Treatment. $3 861470
650 0 $a Rectum $x Cancer $x Diagnosis. $3 1066965
650 0 $a Rectum $x Cancer $x Treatment. $3 861471
650 1 4 $a Cancer Therapy. $3 3594090
650 2 4 $a Cancer Screening. $3 3594091
650 2 4 $a Immunotherapy. $3 597370
650 2 4 $a Biomarkers. $3 2205735
700 1 $a Shukla, Dhananjay. $3 3504762
700 1 $a Vishvakarma, Naveen Kumar. $3 3504761
700 1 $a Nagaraju, Ganji Purnachandra. $3 3274998
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-72702-4
950 $a Biomedical and Life Sciences (SpringerNature-11642)